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Abstract 23	  
Broad-spectrum antimicrobial agents, such as silver, are increasingly being 24	  
formulated into medicated wound dressings in order to control colonization of wounds 25	  
by opportunistic pathogens. Medicated wound dressings have been shown in-vitro to 26	  
be effective against planktonic cultures, but in-vivo bacteria are likely to be present in 27	  
biofilms, which makes their control and eradication more challenging. Recently, a 28	  
functional wound dressing (AQUACEL® Ag+ ExtraTM (AAg+E)) has been developed 29	  
that in addition to silver contains two agents (ethylenediaminetetraacetic acid (EDTA) 30	  
and benzethonium chloride (BC)) designed to disrupt biofilms. Here, the efficacy of 31	  
AAg+E is demonstrated using a biofilm model developed in an isothermal 32	  
microcalorimeter. The biofilm was seen to remain viable in the presence of 33	  
unmedicated dressing, silver-containing dressing or silver nitrate solution. In the 34	  
presence of AAg+E, however, the biofilm was eradicated. Control experiments 35	  
showed that neither EDTA nor BC alone had a bactericidal effect, which means it is 36	  
the synergistic action of EDTA and BC disrupting the biofilm with silver being 37	  
bactericidal that leads to the product’s efficacy. 38	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1. Introduction 45	  
The process of healing of chronic cutaneous wounds is complex and may be affected 46	  
by the presence of microorganisms (Bowler, 2002). In particular, bacterial 47	  
contamination may slow wound healing, result in damage to surrounding tissue and 48	  
ultimately lead to infection of the host (Landis, 2008). Progression to infection may 49	  
also be aided by other factors including poor blood supply to the wound and the 50	  
intrinsic virulence properties of the invading organisms (Siddiqui and Bernstein, 2010; 51	  
Bowler et al, 2001).  52	  
The fact that treatment of bacterial infection at the wound site has the potential 53	  
significantly to reduce the time for wound healing has led to the development of a 54	  
number of medicated wound dressings containing antimicrobial agents. Silver is a 55	  
particularly widely used agent, as it shows broad antimicrobial (against both Gram-56	  
negative and Gram-positive organisms, Miraftab et al, 2014) and anti-fungal activity 57	  
(Bowler et al, 2005), although there is debate as to the specific efficacy of silver (Aziz 58	  
et al, 2012; White and Cutting, 2006) and to its potential toxicity (Hermans, 2006). 59	  
An added complexity in the treatment of chronic wound infections is that the 60	  
organisms are frequently present as biofilms, with this form of bacterial growth being 61	  
increasingly implicated in cases of poor wound healing (Hurlow and Bowler, 2012). 62	  
Evidence for biofilm involvement in chronic wounds comes from macroscopic (Hurlow 63	  
and Bowler, 2012; Metcalf and Bowler, 2013) and microscopic observation of biofilms 64	  
(James et al., 2008; Metcalf and Bowler, 2013). A study involving in vivo wound 65	  
models of a Staphylococcus aureus infection also showed microscopic evidence of 66	  
biofilm formation along with a demonstration of physiological differences between 67	  
planktonic cells and biofilm bacteria recovered from wounds (Davis et al. 2008).  68	  
While the drivers for biofilm formation are not completely clear, experimentally it is 69	  
usually the case that microbial biofilms show reduced antimicrobial susceptibility than 70	  
comparable planktonic organisms (Davis et al, 2008, Percival et al, 2011). Antibiotic 71	  
resistance has been ascribed to several mechanisms, including the production of 72	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inactivating enzymes, the presence of persister cells and the protective effects of 73	  
extracellular polymeric substances (EPS) (Smith, 2005).  74	  
Successful treatment of chronic wound infections therefore requires development of 75	  
next generation of medicated dressings that are efficacious against biofilms. 76	  
AQUACEL® Ag+ ExtraTM (AAg+E) is a recently developed dressing that contains two 77	  
agents that are known to disrupt biofilms, ethylenediaminetetraacetic acid (EDTA) 78	  
and benzethonium chloride (BC), in addition to ionic silver as an antimicrobial agent. 79	  
A recent cohort analysis of wound healing data involving 121 clinical cases showed 80	  
AAg+E to result in progress towards healing in over 90% of wounds which were 81	  
previously stalled, infected or at risk of infection and with a high suspicion of biofilm 82	  
contamination (Metcalf et al, 2014). 83	  
Determination of wound dressing efficacy using analytical or traditional 84	  
microbiological methods is tricky, because of the challenges inherent in determining 85	  
viable bacterial counts in a heterogeneous system. Isothermal microcalorimetry 86	  
(IMC) is one technique that offers potential in this area, since it can detect the power 87	  
resulting from bacterial growth without requiring optical clarity of the sample. We 88	  
showed previously how IMC can be used to quantitate wound dressing efficacy 89	  
(Gaisford et al, 2009; Said et al, 2014) against planktonic cultures of two common 90	  
wound pathogens. To use IMC to investigate the efficacy of AAg+E against biofilms, 91	  
however, requires development of a biofilm model. Hence, the specific aim of this 92	  
work was to develop a biofilm model suitable for use with IMC and to use the model 93	  
to explore the efficacy of AAg+E. 94	  
 95	  
2. Material and Methods 96	  
Ethylenediaminetetraacetic acid (EDTA), benzethonium chloride (BC) and silver 97	  
nitrate (AgNO3) were purchased from Sigma (UK) and used as received. Wound 98	  
dressings, AQUACEL® (AH), AQUACEL® Ag (AAgH) or AQUACEL® Ag Extra 99	  
(AAg+E) were supplied by ConvaTec Ltd. The wound dressings, all comprised of 100	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sodium carboxymethylcellulose fibres, differ in that AH has no antimicrobial agent 101	  
while AAgH contains ionic silver and AAg+E contains ionic silver, EDTA and BC. 102	  
The challenge organism, Staphylococcus aureus NCIMB 9518, was grown overnight 103	  
in nutrient broth (NB; Oxoid Ltd) for 16h at 37 oC. Cells were then harvested, washed 104	  
in phosphate buffered saline (PBS), resuspended in 15 %v/v glycerol at an organism 105	  
density of 108 cfu/ml and frozen in aliquots (1 mL) over liquid nitrogen (Beezer et al, 106	  
1976; Cosgrove, 1979). Aliquots were stored under liquid nitrogen until required. 107	  
Previous experience (data not shown) has indicated that organisms can be stored for 108	  
over 6 years in this frozen state and remain viable post thawing with less than 1% 109	  
decrease in viability.  110	  
Ampoules were prepared by adding molten agar (300 µL, Agar No. 3, Oxoid), which 111	  
was allowed to set. Tryptone soya broth (TSB, 1 mL) was added to prepared 112	  
ampoules and inoculated with S. aureus to a final population density of 1x106 cfu/mL. 113	  
The ampoules were then sealed and incubated at 37 oC with agitation for 24 hours. 114	  
Thereafter, the ampoules were opened and the TSB was carefully poured out. The 115	  
ampoules were gently rinsed with sterile distilled water a minimum of five times to 116	  
ensure effective removal of planktonic cells. Fresh, sterile TSB (1 mL) and where 117	  
required wound dressing (3.3 mg), EDTA (0.14% w/v), BC (0.4% w/v) or AgNO3 (1 x 118	  
10-4 M) was then added to the ampoules, which were hermetically sealed and placed 119	  
into calorimeters.  120	  
Cell counts were determined after each calorimetric experiment. After removal of 121	  
TSB and extensive rinsing, as above, fresh PBS was added to ampoules, which were 122	  
then sealed. Ampoules were then briefly vortexed before being sonicated for a period 123	  
of 5 minutes. Colony counts were determined by serially diluting the PBS from the 124	  
ampoules and spread plating onto iso-sensitest agar. Colonies were counted 125	  
following 16h incubation at 37 oC. 126	  
Calorimetric data were recorded with a 2277 Thermal Activity Monitor (TAM; TA 127	  
Instruments Ltd, UK) operated at 37 oC. Data capture was initiated exactly 30 min 128	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post inoculation with the dedicated software package Digitam 4.1 (1 data point every 129	  
10 s, amplifier setting 300 µW). The instrument was calibrated periodically by the 130	  
electrical substitution method. Data were analysed using Origin 8.1 (Microcal 131	  
Software Inc). 132	  
 133	  
3. Results and Discussion 134	  
Although not discussed here, it was not possible to culture a biofilm directly onto the 135	  
glass walls of the ampoule. Rather, the agar layer was necessary to encourage 136	  
biofilm attachment and growth. A similar effect has been noted in ecological research 137	  
where a twofold increase in the accumulation of diatoms (phytoplanktonic algae) was 138	  
seen on a surface when unenriched agar was added (Stevenson, 1983). The 139	  
rationale in that study was the use of agar to ‘simulate mucilage of immigrating 140	  
organisms’, in other words to create a ‘slimy’, polymeric conditioning film. In relation 141	  
to in vivo correlation it has been suggested that the use of agar simulates a microbial 142	  
colonisation of a moist surface, similar to wounds (Daeschlein, 2010).  143	  
The physiology of cells in biofilms is distinct from those in planktonic culture because 144	  
of their sessile nature and differences in exposure to nutrients and gases in their 145	  
microenvironment (Stewart and Franklin, 2008). Diffusion is the main mechanism of 146	  
delivery of solutes to biofilm clusters (Stewart, 2003) and so concentration gradients 147	  
exist that depend on the thickness of the biofilm. It follows that delivery of 148	  
antimicrobial agents will similarly be rate limited by this diffusion mechanism, and 149	  
their efficacy may be reduced relative to planktonic cultures (up to a 1000 fold 150	  
decrease in susceptibility has been reported, Stewart and Costerton, 2001).  151	  
Similarly, the power produced by an established biofilm will differ from that of a 152	  
planktonic culture. As has been discussed in the literature (Braissant et al, 2010; 153	  
Said et al, 2014) the power output from planktonic cultures will show a series of 154	  
exothermic peaks and troughs with time as the organisms utilise the available 155	  
nutrients to increase in number. Integration of the power data with respect to time 156	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gives a plot of cumulative heat versus time, which is comparable to the standard 157	  
growth curves determined with optical density (OD) readings.  158	  
Typical power-time data for S. aureus biofilms are shown in Figure 1. Biofilms were 159	  
found not to give as repeatable data as planktonic cultures. Similar variability was 160	  
seen in a study by Astasov-Frauenhoffer et al (2012). However, the degree of 161	  
variability was small enough to permit study of the efficacy of the dressing. It is 162	  
apparent that there is an exothermic peak initially, followed by a smaller, but 163	  
persistent, exothermic power. It is assumed that the initial peak represents either 164	  
growth of planktonic cells released from the biofilm or growth and metabolism within 165	  
the biofilms themselves. The power then resolves to a non-zero baseline, which is 166	  
assumed to be associated with biofilm metabolism.  167	  
The presence of the initial exotherm is surprising. Following 24 hours incubation, the 168	  
putative biofilm samples were extensively rinsed in order to remove planktonic cells. 169	  
Each rinsing can be considered as a 1:1 dilution as the volume of diluent used was 170	  
equivalent to that of the original growth medium in the culture. As such, very little or 171	  
no power, or at least a significant delay in onset of power signals, would be expected 172	  
from planktonic cells as these would have been diluted down to undetectable levels 173	  
(given that the lower limit of detection for IMC is approximately 1x105 – 1x106 cfu/mL, 174	  
Said et al, 2014).  175	  
Cell counts for biofilm samples suggest a potential explanation. Immediately following 176	  
preparation (i.e. before being loaded into the calorimeter) the average cell count was 177	  
4x107 cfu/mL. After 24 h in the calorimeter, the average cell count had increased to 178	  
1x108 cfu/mL. This suggests that cell division continues within the biofilm, presumably 179	  
until the available nutrients and/or gases in the fresh medium are exhausted, after 180	  
which the system reverts to a stasis metabolism. An alternative explanation is that 181	  
since rinsing will disturb the isotonic balance of the system, the biofilm responds by 182	  
dispersing bacteria from the film as a survival response. These bacteria then grow as 183	  
a planktonic population. 184	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The corresponding cumulative heat plot for the biofilm is shown in Figure 2 (all further 185	  
data are shown as cumulative heat plots for familiarity and ease of comparison with 186	  
OD data). 187	  
Previously (Said et al, 2014) we showed that AgNO3 at a concentration of 1 x 10-4 M 188	  
was bactericidal against planktonic S. aureus. Figure 3 shows the growth curves for 189	  
planktonic and biofilm cultures in the presence of this silver concentration. As 190	  
expected, no growth is seen in planktonic culture, but the biofilm culture shows 191	  
growth following an initial delay. The average cell count following the calorimetric 192	  
experiment was 1.5 x 107 cfu/mL, not much lower than that recorded for the 193	  
untreated biofilm, which confirms that biofilm formation confers on the participant 194	  
organisms a significant degree of protection against antimicrobial agents. 195	  
The implication of this finding is that a wound dressing containing silver alone might 196	  
be less effective against a biofilm culture, and this effect is indeed observed 197	  
experimentally, Figure 4. Dressing alone (AH) did not inhibit growth, while silver-198	  
containing dressing (AAgH) only delayed growth (the same effect noted above in the 199	  
silver nitrate experiments).  200	  
Successful eradication of an established biofilm requires delivery of agents to disrupt 201	  
biofilm structure in addition to an antimicrobial compound. This is the formulation 202	  
strategy behind AAg+E and the data in Figure 4 show a significant reduction in 203	  
growth with this dressing. The average cell count following exposure to AAg+E was 2 204	  
x 104 cfu/mL, so the dressing can be deemed to be bactericidal in nature because it 205	  
induced a 3 log reduction in viable cells relative to the control. 206	  
The question then remains as to the relative contributions of the components in 207	  
AAg+E to the overall efficacy of the dressing. Biofilms were exposed to solutions 208	  
containing only AgNO3, only EDTA and BC or all three components (Figure 5). In all 209	  
cases a small amount of AH (i.e. plain dressing) was included, the intention being to 210	  
imitate the action of a dressing containing only these components. It is apparent that 211	  
EDTA and BC cause an initial delay but then growth is seen which is identical to the 212	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control. We noted previously that the presence of AH can alter the kinetics of growth 213	  
(Said et al, 2014), possibly because the hydrofiber network can sequester planktonic 214	  
bacteria, changing the rate of supply of nutrients and altering local pH. It is also 215	  
possible that the hydrofiber itself can cause physical disruption of a biofilm. An effect 216	  
on growth rate in the presence of AH is seen in Figure 4. (Silver nitrate is seen to 217	  
inhibit growth for at least 10h, after which growth similar to the control is seen. In 218	  
neither case therefore do these components act to inhibit the biofilm. When they are 219	  
added in combination, however, a reduction in growth is seen, which confirms the 220	  
hypothesis that it is the combination of biofilm disrupters and an antimicrobial agent 221	  
working in synergy that is necessary for efficacy.  222	  
The effect of EDTA has been attributed to its properties as a metal chelator, since the 223	  
chelation of divalent cations that are important in ensuring the structural integrity of 224	  
cells causes disruption and prolonged exposure may result in a biocidal effect (Banin 225	  
et al., 2005). Certain divalent cations have also been indicated in the structural 226	  
integrity of the biofilm EPS matrix (Banin et al., 2005; Percival et al., 2005) and 227	  
sequestration of these cations may result in dispersal of the biofilm.  228	  
EDTA may also play a role in the delivery of silver to the bacteria. Since silver is 229	  
contained in the dressing in its ionic form, delivery to its site of action will be affected 230	  
both by the concentration of free silver in solution and the relative association 231	  
constants between silver and components in solution and the bacterial cell wall. It is 232	  
likely that binding to EDTA affects the relative positions of these association 233	  
constants, and since the silver appears to have faster action in the presence of EDTA 234	  
the data imply the association constant of silver with EDTA is fast, ensuring silver 235	  
ions are rapidly removed from the dressing, but not as strong as the association 236	  
constants of silver with the cells. 237	  
BC, on the other hand, is a surfactant. In high concentrations BC has antiseptic and 238	  
anti-infective properties that have been shown to have anti-biofilm activity against 239	  
oral fungal biofilms (Ichikawa et al., 2008), but the concentrations achieved from 240	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AAg+E are below the MIC. Thus, BC acts to reduce surface tension, affecting biofilm 241	  
architecture and cell-cell interactions (Davey et al., 2003), promoting the activity of 242	  
silver when delivered with EDTA. 243	  
4. Summary 244	  
 245	  
A biofilm model was developed that enabled the use of IMC to test the efficacy of an 246	  
anti-biofilm wound dressing. It was shown that a broad spectrum antimicrobial agent 247	  
alone was not effective against the biofilm but that when biofilm disrupting agents 248	  
were included in the dressing bactericidal action was seen. 249	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Figure 1: Power-time data for biofilms grown on agar, showing the level of 373	  
reproducibility for three samples.374	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Figure 2: Power-time data for the control biofilm (bottom) and corresponding 377	  
growth curve (top) 378	  
 379	  380	  
	   18	  
0 5 10 15 20
-0.5
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
C
um
m
ul
at
iv
e 
he
at
 / 
J
Time / h
Biofilm
Planktonic
 381	  
 382	  
Figure 3: Growth curves for planktonic and biofilm cultures in the presence of 383	  
1 x 10-4 M AgNO3. 384	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Figure 4: Growth curves for biofilms in the presence of AH, AAgH and AAg+E. 388	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Figure 5: Growth curves for biofilm alone and in the presence of AgNO3, EDTA 392	  
+ BC and AgNO3 + EDTA + BC. 393	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